← Browse by Condition
Medical Condition

keratoconus

Total Trials
8
Recruiting Now
8
Trial Phases
Phase 3

ClinicalMetric tracks all active clinical trials for keratoconus sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — keratoconus Clinical Trials

How many clinical trials are currently recruiting for keratoconus?
ClinicalMetric currently tracks 8 actively recruiting clinical trials for keratoconus, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 8. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for keratoconus?
keratoconus research spans Phase 3 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a keratoconus clinical trial?
Eligibility criteria for keratoconus trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3
2
Top Sponsors
Woolfson Eye Institute 2 trials
Oslo University Hospital 1 trial
Boston Children's Hospital 1 trial
Technische Universität Dresden 1 trial
Universität des Saarlandes 1 trial

Recruiting Clinical Trials

NCT06264024
Recruiting
Simultaneous pHototherapeutic Keratectomy and corneAl Collagen cRosslinking in Eyes With Keratoconus: a Randomized Trial (SHARK)
Enrollment
81 pts
Location
Norway
Sponsor
Oslo University Hospital
View Trial →
NCT07124910 Phase 3
Recruiting
Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases
Enrollment
485 pts
Location
United States
Sponsor
Woolfson Eye Institute
View Trial →
NCT07135167 Phase 3
Recruiting
Compassionate Use Study of Epi-ON Corneal Collagen Crosslinking Performed Using UVA Exposure on Eyes With Ectatic Corneal Diseases for Subjects With Down Syndrome
Enrollment
225 pts
Location
United States
Sponsor
Woolfson Eye Institute
View Trial →
NCT04439552
Recruiting
fMRI and IVCM Cornea Microscopy of CXL in Keratoconus
Enrollment
60 pts
Location
United States
Sponsor
Boston Children's Hospital
View Trial →
NCT04251143
Recruiting
Dresden Corneal Disease and Treatment Study
Enrollment
700 pts
Location
Germany
Sponsor
Technische Universität Dresden
View Trial →
NCT03923101
Recruiting
The Homburg Keratoconus Center (HKC)
Enrollment
5,000 pts
Location
Germany
Sponsor
Universität des Saarlandes
View Trial →
NCT06451718
Recruiting
First in Human Study to Assess Safety and Efficacy of an Implantable Nitinol Device in the Treatment of Keratoconus
Enrollment
12 pts
Location
Italy, Spain
Sponsor
Recornea Srl
View Trial →
NCT06921967
Recruiting
Effect of Corneal and Scleral RGP Lenses on Ocular Health and Visual Quality in Keratoconus
Enrollment
50 pts
Location
Denmark
Sponsor
University of Aarhus
View Trial →

Related Conditions

forme fruste keratoconus ffk (2) ectasia of cornea (1) pellucid marginal corneal degeneration (1) down syndrome ds (1) pellucid marginal degeneration (1) pain postoperative (1) pain chronic (1) pain acute (1) surgical injury (1) surgical wound (1) cornea injury (1) cornea (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology